A Randomized, Double-Blind, Cross-Over, Placebo-Controlled Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine
Phase of Trial: Phase I/II
Latest Information Update: 14 Jul 2017
Price : $35 *
At a glance
- Drugs Ketoprofen (Primary)
- Indications Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- Sponsors Achelios Therapeutics
- 21 Dec 2015 Results published for phase IIa part of the study in Achelios Therapeutics media release.
- 26 Jan 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 06 Nov 2014 Planned End Date changed from 1 Sep 2014 to 1 Nov 2014, according to the ClinicalTrials.gov record.